Current perspectives on the diagnosis and management of fatigue in multiple sclerosis

References

• Rooney S, Wood L, Moffat F, et al. Prevalence of fatigue and its association with clinical features in progressive and non-progressive forms of Multiple Sclerosis. Mult Scler Relat Disord. 2019;28:276–282.
   PubMed Web of Science ®Google Scholar
• Ramirez AO, Keenan A, Kalau O, et al. Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review. BMC Neurol. 2021;21(1):468.
   PubMed Web of Science ®Google Scholar
• Rommer PS, Eichstädt K, Ellenberger D, et al. Symptomatology and symptomatic treatment in multiple sclerosis: results from a nationwide MS registry. Mult Scler. 2019;25(12):1641–1652.
   PubMed Web of Science ®Google Scholar
• de Vries RMV, van den Dorpel JJ, Mescheriakova JY, et al. Fatigue after a first attack of suspected multiple sclerosis. Mult Scler J. 2018;24(7):974–981.
   PubMed Web of Science ®Google Scholar
• Runia TF, Jafari N, Siepman DAM, et al. Fatigue at time of CIS is an independent predictor of a subsequent diagnosis of multiple sclerosis. J Neurol Neurosurg Psychiatry. 2015;86(5):543–546.
   PubMed Web of Science ®Google Scholar
• Berger JR, Pocoski J, Preblick R, et al. Fatigue heralding multiple sclerosis. Mult Scler. 2013;19(11):1526–1532.
   PubMedGoogle Scholar
• Yusuf F, Wijnands JM, Kingwell E, et al. Fatigue, sleep disorders, anaemia and pain in the multiple sclerosis prodrome. Mult Scler. 2021;27(2):290–302.
   PubMedGoogle Scholar
• Ivaniuk A, Solodovnikova Y, Marusich T, et al. The impairment of the functional system and fatigue at the onset of the disease predict reaching disability milestones in relapsing-remitting multiple sclerosis differently in female and male patients. Acta Neurol Belg. 2021;121(6):1699–1706.
   PubMed Web of Science ®Google Scholar
• Kluger BM, Krupp LB, Enoka RM. Fatigue and fatigability in neurologic illnesses Proposal for a unified taxonomy. Neurology. 2013;80(4):409–416.
   PubMed Web of Science ®Google Scholar
• Guidelines MSCFCP. Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis: clinical practice guidelines. Washington D.C.: Paralyzed Veterans of America; 1998.
   Google Scholar
• Cehelyk EK, Harvey DY, Grubb ML, et al. Uncovering the association between fatigue and fatigability in multiple sclerosis using cognitive control. Mult Scler Relat Disord. 2019;27:269–275.
   PubMed Web of Science ®Google Scholar
• Coates KD, Aboodarda SJ, Krüger RL, et al. Multiple sclerosis-related fatigue: the role of impaired corticospinal responses and heightened exercise fatigability. J Neurophysiol. 2020;124(4):1131–1143.
   PubMed Web of Science ®Google Scholar
• Bakirtzis C, Nikolaidis I, Boziki M-K, et al. Cognitive fatigability is independent of subjective cognitive fatigue and mood in multiple sclerosis. Cogn Behav Neurol. 2020;33(2):113–121.
   PubMed Web of Science ®Google Scholar
• Spiteri S, Hassa T, Claros-Salinas D, et al. Neural correlates of effort-dependent and effort-independent cognitive fatigue components in patients with multiple sclerosis. Mult Scler. 2019;25(2):256–266.
   PubMed Web of Science ®Google Scholar
• Miller DM, Shindell S, Lublin F. Developing multiple sclerosis practice guidelines: the multiple sclerosis council for clinical practice guidelines. Ann Neurol. 1998;44(3): 519-519.
   Web of Science ®Google Scholar
• Powell DJH, Liossi C, Schlotz W, et al. Tracking daily fatigue fluctuations in multiple sclerosis: ecological momentary assessment provides unique insights. J Behav Med. 2017;40(5):772–783.
   PubMed Web of Science ®Google Scholar
• Palotai M, Cavallari M, Healy BC, et al. A novel classification of fatigue in multiple sclerosis based on longitudinal assessments. Mult Scler. 2020;26(6):725–734.
   PubMed Web of Science ®Google Scholar
• Young CA, Mills R, Rog D, et al. Quality of life in multiple sclerosis is dominated by fatigue, disability and self-efficacy. J Neurol Sci. 2021; 426:117437.
   PubMed Web of Science ®Google Scholar
• Salter A, Fox RJ, Tyry T, et al. The association of fatigue and social participation in multiple sclerosis as assessed using two different instruments. Mult Scler Relat Disord. 2019;31:165–172.
   PubMed Web of Science ®Google Scholar
• Slusarz R, Olkiewicz J, Bonek R, et al. The impact of motor disability and the level of fatigue on adherence to therapeutic recommendations in patients with multiple sclerosis treated with immunomodulation. Int J Med Sci. 2021;18(15):3609–3614.
   PubMed Web of Science ®Google Scholar
• Erbay O, Yesilbalkan OU, Yuceyar N. Factors affecting the adherence to disease-modifying therapy in patients with multiple sclerosis. J Neurosci Nurs. 2018;50(5):291–297.
   PubMedGoogle Scholar
• Donzé C, Malapel L, Kwiatkowski A, et al. Treatment discontinuation in multiple sclerosis: the French Web-based survey ALLIANCE. Mult Scler J Exp Transl Clin. 2015;1:2055217315600720.
   Google Scholar
• McGinley MP, Goldschmidt CH, and Rae-Grant AD. Diagnosis and treatment of multiple sclerosis: a review. JAMA. 2021;325(8):765–779
   PubMed Web of Science ®Google Scholar
• Leavitt VM, De Meo E, Riccitelli G, et al. Elevated body temperature is linked to fatigue in an Italian sample of relapsing-remitting multiple sclerosis patients. J Neurol. 2015;262(11):2440–2442.
   PubMed Web of Science ®Google Scholar
• Sumowski JF, Leavitt VM. Body temperature is elevated and linked to fatigue in relapsing-remitting multiple sclerosis, even without heat exposure. Arch Phys Med Rehabil. 2014;95(7):1298–1302.
   PubMed Web of Science ®Google Scholar
• Chaseling GK, Allen DR, Vucic S, et al. Core temperature is not elevated at rest in people with relapsing-remitting multiple sclerosis. Mult Scler Relat Disord. 2019;29:62–67.
   PubMed Web of Science ®Google Scholar
• Dittner AJ, Wessely SC, Brown RG. The assessment of fatigue - A practical guide for clinicians and researchers. J Psychosom Res. 2004;56(2):157–170.
   PubMed Web of Science ®Google Scholar
• Linnhoff S, Fiene M, Heinze HJ, et al. Cognitive fatigue in multiple sclerosis: an objective approach to diagnosis and treatment by transcranial electrical stimulation. Brain Sci. 2019;9(5):100.
   Web of Science ®Google Scholar
• Fisk JD, Ritvo PG, Ross L, et al. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis. 1994;18 Suppl 1:S79–83.
   PubMed Web of Science ®Google Scholar
• Krupp LB, LaRocca NG, Muir-Nash J, et al. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121–1123.
   PubMed Web of Science ®Google Scholar
• Sellitto G, Morelli A, Bassano S, et al. Outcome measures for physical fatigue in individuals with multiple sclerosis: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2021;21(4):625–646.
   PubMed Web of Science ®Google Scholar
• Marchesi O, Vizzino C, Meani A, et al., Fatigue in multiple sclerosis patients with different clinical phenotypes: a clinical and magnetic resonance imaging study. Eur J Neurol. 2020;27(12): 2549–2560.
   PubMed Web of Science ®Google Scholar
• Strober LB, Bruce JM, Arnett PA, et al. Tired of not knowing what that fatigue score means? Normative data of the modified fatigue impact scale (MFIS). Mult Scler Relat Disord. 2020;46:102576.
   PubMed Web of Science ®Google Scholar
• Flachenecker P, Kümpfel T, Kallmann B, et al. Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler J. 2002;8(6):523–526.
   PubMed Web of Science ®Google Scholar
• Schwartz JE, Jandorf L, Krupp LB. The measurement of fatigue: a new instrument. J Psychosom Res. 1993;37(7):753–762.
   PubMed Web of Science ®Google Scholar
• Penner IK, Raselli C, Stöcklin M, et al. The fatigue scale for motor and cognitive functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue. Mult Scler. 2009;15(12):1509–1517.
   PubMed Web of Science ®Google Scholar
• Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377–381.
   PubMed Web of Science ®Google Scholar
• Flachenecker P, Müller G, König H, et al. [“Fatigue” in multiple sclerosis. Development and and validation of the “Würzburger Fatigue Inventory for MS”]. Nervenarzt. 2006;77(2):165–6, 168–70, 172–4.
   Google Scholar
• Loy BD, Taylor RL, Fling BW, et al. Relationship between perceived fatigue and performance fatigability in people with multiple sclerosis: a systematic review and meta-analysis. J Psychosom Res. 2017;100:1–7.
   PubMed Web of Science ®Google Scholar
• Enoka RM, Almuklass AM, Alenazy M, et al. Distinguishing between fatigue and fatigability in multiple sclerosis. Neurorehabil Neural Repair. 2021;35(11):960–973.
   PubMed Web of Science ®Google Scholar
• Mackay L, Johnson AM, Moodie ST, et al. Predictors of cognitive fatigue and fatigability in multiple sclerosis. Mult Scler Relat Disord. 2021;56:103316.
   PubMed Web of Science ®Google Scholar
• Pravatà E, Zecca C, Sestieri C, et al. Hyperconnectivity of the dorsolateral prefrontal cortex following mental effort in multiple sclerosis patients with cognitive fatigue. Mult Scler. 2016;22(13):1665–1675.
   PubMed Web of Science ®Google Scholar
• Malekzadeh A, Van de Geer-Peeters W, De Groot V, et al. Fatigue in patients with multiple sclerosis: is it related to pro- and anti-inflammatory cytokines? Dis Markers. 2015;2015:758314.
   PubMed Web of Science ®Google Scholar
• Brenner P, Granqvist M, Königsson J, et al. Depression and fatigue in multiple sclerosis: relation to exposure to violence and cerebrospinal fluid immunomarkers. Psychoneuroendocrinology. 2018;89:53–58.
   PubMed Web of Science ®Google Scholar
• Flachenecker P, Bihler I, Weber F, et al. Cytokine mRNA expression in patients with multiple sclerosis and fatigue. Mult Scler. 2004;10(2):165–169.
   PubMed Web of Science ®Google Scholar
• Gottschalk M, Kümpfel T, Flachenecker P, et al. Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis. Arch Neurol. 2005;62(2):277–280.
   PubMedGoogle Scholar
• Téllez N, Comabella M, Julià E, et al. Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone. Mult Scler. 2006;12(4):487–494.
   PubMed Web of Science ®Google Scholar
• Codella M, Rocca MA, Colombo B, et al. Cerebral grey matter pathology and fatigue in patients with multiple sclerosis: a preliminary study. J Neurol Sci. 2002;194(1):71–74.
   PubMed Web of Science ®Google Scholar
• Codella M, Assunta Rocca M, Colombo B, et al. A preliminary study of magnetization transfer and diffusion tensor MRI of multiple sclerosis patients with fatigue. J Neurol. 2002;249(5):535–537.
   PubMed Web of Science ®Google Scholar
• Filippi M, Preziosa P, Rocca MA. Brain mapping in multiple sclerosis: lessons learned about the human brain. Neuroimage. 2019;190:32–45.
   PubMed Web of Science ®Google Scholar
• Sheean GL, Murray NM, Rothwell JC, et al. An electrophysiological study of the mechanism of fatigue in multiple sclerosis. Brain. 1997;120(Pt 2):299–315.
   PubMedGoogle Scholar
• Roelcke U, Kappos L, Lechner-Scott J, et al., Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study. Neurology. 1997;48(6): 1566–1571.
   PubMed Web of Science ®Google Scholar
• Rocca MA, Parisi L, Pagani E, et al., Regional but not global brain damage contributes to fatigue in multiple sclerosis. Radiology. 2014; 273(2): 511–520.
   PubMed Web of Science ®Google Scholar
• Palotai M, Guttmann CR. Brain anatomical correlates of fatigue in multiple sclerosis. Mult Scler. 2020;26(7):751–764.
   PubMed Web of Science ®Google Scholar
• Palotai M, Nazeri A, Cavallari M, et al. History of fatigue in multiple sclerosis is associated with grey matter atrophy. Sci Rep. 2019;9(1):14781.
   PubMedGoogle Scholar
• Fuchs TA, Vaughn CB, Benedict RHB, et al. Lower self-report fatigue in multiple sclerosis is associated with localized white matter tract disruption between amygdala, temporal pole, insula, and other connected structures. Mult Scler Relat Disord. 2019;27:298–304.
   PubMed Web of Science ®Google Scholar
• Sepulcre J, Masdeu JC, Goñi J, et al. Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways. Mult Scler. 2009;15(3):337–344.
   PubMed Web of Science ®Google Scholar
• Mainero C, Faroni J, Gasperini C, et al. Fatigue and magnetic resonance imaging activity in multiple sclerosis. J Neurol. 1999;246(6):454–458.
   PubMed Web of Science ®Google Scholar
• Putzki N, Yaldizli Ö, Tettenborn B, et al. Multiple sclerosis associated fatigue during natalizumab treatment. J Neurol Sci. 2009;285(1–2):109–113.
   PubMed Web of Science ®Google Scholar
• Bertoli M, Tecchio F. Fatigue in multiple sclerosis: does the functional or structural damage prevail? Mult Scler. 2020;26(14):1809–1815.
   PubMed Web of Science ®Google Scholar
• Genova HM, Rajagopalan V, DeLuca J, et al. Examination of cognitive fatigue in multiple sclerosis using functional magnetic resonance imaging and diffusion tensor imaging. PLoS One. 2013;8(11):e78811.
   PubMed Web of Science ®Google Scholar
• Mainero C, Inghilleri M, Pantano P, et al. Enhanced brain motor activity in patients with MS after a single dose of 3,4-diaminopyridine. Neurology. 2004;62(11):2044–2050.
   PubMed Web of Science ®Google Scholar
• Rocca MA, Agosta F, Colombo B, et al., fMRI changes in relapsing-remitting multiple sclerosis patients complaining of fatigue after IFNbeta-1a injection. Hum Brain Mapp.2007; 28(5): 373–382.
   PubMed Web of Science ®Google Scholar
• Rocca MA, Meani A, Riccitelli GC, et al. Abnormal adaptation over time of motor network recruitment in multiple sclerosis patients with fatigue. Mult Scler. 2016;22(9):1144–1153.
   PubMed Web of Science ®Google Scholar
• Bisecco A, Nardo FD, Docimo R, et al. Fatigue in multiple sclerosis: the contribution of resting-state functional connectivity reorganization. Mult Scler. 2018;24(13):1696–1705.
   PubMed Web of Science ®Google Scholar
• Hidalgo de la Cruz M, d'Ambrosio A, Valsasina P, et al. Abnormal functional connectivity of thalamic sub-regions contributes to fatigue in multiple sclerosis. Mult Scler. 2018;24(9):1183–1195.
   PubMed Web of Science ®Google Scholar
• Jaeger S, Paul F, Scheel M, et al. Multiple sclerosis-related fatigue: altered resting-state functional connectivity of the ventral striatum and dorsolateral prefrontal cortex. Mult Scler. 2019;25(4):554–564.
   PubMed Web of Science ®Google Scholar
• Stefancin P, Govindarajan ST, Krupp L, et al. Resting-state functional connectivity networks associated with fatigue in multiple sclerosis with early age onset. Mult Scler Relat Disord. 2019;31:101–105.
   PubMed Web of Science ®Google Scholar
• Arm J, Oeltzschner G, Al-iedani O, et al. Altered in vivo brain GABA and glutamate levels are associated with multiple sclerosis central fatigue. Eur J Radiol. 2021;137:109610.
   PubMed Web of Science ®Google Scholar
• Filippi M, Rocca MA, Colombo B, et al. Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Neuroimage. 2002;15(3):559–567.
   PubMed Web of Science ®Google Scholar
• Veldhuijzen van Zanten J, Douglas MR, Ntoumanis N. Fatigue and fluctuations in physical and psychological wellbeing in people with multiple sclerosis: a longitudinal study. Mult Scler Relat Disord. 2021;47:102602.
   PubMed Web of Science ®Google Scholar
• Krupp LB, Christodoulou C. Fatigue in multiple sclerosis. Curr Neurol Neurosci Rep. 2001;1(3):294–298.
   PubMed Web of Science ®Google Scholar
• AlSaeed S, Aljouee T, Alkhawajah NM, et al. Fatigue, depression, and anxiety among ambulating multiple sclerosis patients. Front Immunol. 2022;13:844461.
   PubMedGoogle Scholar
• Fidao A, De Livera A, Nag N, et al. Depression mediates the relationship between fatigue and mental health-related quality of life in multiple sclerosis. Mult Scler Relat Disord. 2021;47:102620.
   PubMed Web of Science ®Google Scholar
• Greeke EE, Chua AS, Healy BC, et al. Depression and fatigue in patients with multiple sclerosis. J Neurol Sci. 2017;380:236–241.
   PubMed Web of Science ®Google Scholar
• Schmidt S, Jöstingmeyer P. Depression, fatigue and disability are independently associated with quality of life in patients with multiple Sclerosis: results of a cross-sectional study. Mult Scler Relat Disord. 2019;35:262–269.
   PubMed Web of Science ®Google Scholar
• Hu M, Muhlert N, Robertson N, et al. Perceived fatigue and cognitive performance change in multiple sclerosis: uncovering predictors beyond baseline fatigue. Mult Scler Relat Disord. 2019;32:46–53.
   PubMed Web of Science ®Google Scholar
• Sindermann C, Saliger J, Nielsen J, et al. Personality and primary emotional traits: disentangling multiple sclerosis related fatigue and depression. Arch Clin Neuropsychol. 2018;33(5):552–561.
   PubMed Web of Science ®Google Scholar
• Del Piccolo L, Pietrolongo E, Radice D, et al. Patient expression of emotions and neurologist responses in first multiple sclerosis consultations. PLoS One. 2015;10(6):e0127734.
   PubMed Web of Science ®Google Scholar
• Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio TX: Psychological Corporation; 1996.
   Google Scholar
• Honarmand K, Feinstein A. Validation of the hospital anxiety and depression scale for use with multiple sclerosis patients. Mult Scler. 2009;15(12):1518–1524.
   PubMed Web of Science ®Google Scholar
• Betscher E, Guenter W, Langdon DW, et al. Polish validation of the brief international cognitive assessment for multiple sclerosis (BICAMS battery): correlation of cognitive impairment with mood disorders and fatigue. Neurol Neurochir Pol. 2021;55(1):59–66.
   PubMed Web of Science ®Google Scholar
• Morrow SA, Weinstock-Guttman B, Munschauer FE, et al. Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis. Mult Scler. 2009;15(8):998–1005.
   PubMed Web of Science ®Google Scholar
• Nourbakhsh B, Julian L, Waubant E. Fatigue and depression predict quality of life in patients with early multiple sclerosis: a longitudinal study. Eur J Neurol. 2016;23(9):1482–1486.
   PubMed Web of Science ®Google Scholar
• McNicholas N, Tubridy N, Hutchinson M, et al. Perceived and objective cognitive impairment in newly diagnosed versus established multiple sclerosis: impact of disease duration. Ir J Med Sci. 2021;190(3):1149–1154.
   PubMed Web of Science ®Google Scholar
• Lazarevic S, Azanjac Arsic A, Aleksic D, et al. Depression and fatigue in patients with multiple sclerosis have no influence on the parameters of cognitive evoked potentials. J Clin Neurophysiol. 2021;38(1):36–42.
   PubMed Web of Science ®Google Scholar
• Andreasen AK, Iversen P, Marstrand L, et al. Structural and cognitive correlates of fatigue in progressive multiple sclerosis. Neurol Res. 2019;41(2):168–176.
   PubMed Web of Science ®Google Scholar
• Kotterba S, Neusser T, Norenberg C, et al. Sleep quality, daytime sleepiness, fatigue, and quality of life in patients with multiple sclerosis treated with interferon beta-1b: results from a prospective observational cohort study. BMC Neurol. 2018;18(1):123.
   PubMedGoogle Scholar
• Gustavsen S, Olsson A, Søndergaard HB, et al. The association of selected multiple sclerosis symptoms with disability and quality of life: a large Danish self-report survey. BMC Neurol. 2021;21(1):317.
   PubMed Web of Science ®Google Scholar
• Cederberg KLJ, Jeng B, Sasaki JE, et al. Demographic, clinical, and symptomatic correlates of subjective sleep quality in adults with multiple sclerosis. Mult Scler Relat Disord. 2021;55:103204.
   PubMed Web of Science ®Google Scholar
• Abdel Salam OA, Ghonimi NAM, Ismail MH. Risk of obstructive sleep apnea in multiple sclerosis: frequency, clinical and radiological correlates. Mult Scler Relat Disord. 2019;28:184–188.
   PubMed Web of Science ®Google Scholar
• Johansson K, Wasling P, Axelsson M. Fatigue, insomnia and daytime sleepiness in multiple sclerosis versus narcolepsy. Acta Neurol Scand. 2021;144(5):566–575.
   PubMed Web of Science ®Google Scholar
• Hare CJ, Crangle CJ, Carney CE, et al. Insomnia symptoms, subjective appraisals, and fatigue: a multiple mediation model. Behav Sleep Med. 2019;17(3):269–280.
   PubMed Web of Science ®Google Scholar
• Dubessy AL, Tezenas du Montcel S, Viala F, et al. Association of central hypersomnia and fatigue in patients with multiple sclerosis: a polysomnographic study. Neurology. 2021;97(1):e23–e33.
   PubMed Web of Science ®Google Scholar
• Simone IL, Ceccarelli A, Tortorella C, et al. Influence of Interferon beta treatment on quality of life in multiple sclerosis patients. Health Qual Life Outcomes. 2006;4(1):96.
   PubMedGoogle Scholar
• Yildiz M, Tettenborn B, Borgwardt S. Trajectory of fatigue severity in natalizumab treated multiple sclerosis patients. Clin Neurol Neurosurg. 2013;115(7):902–903.
   PubMed Web of Science ®Google Scholar
• Polman CH, O’Connor PW, Havrdova E, et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med. 2006;354(9):899–910.
   PubMed Web of Science ®Google Scholar
• de Sèze J, Devy R, Planque E, et al. Fatigue in teriflunomide-treated patients with relapsing remitting multiple sclerosis in the real-world Teri-FAST study. Mult Scler Relat Disord. 2021;47:102659.
   PubMed Web of Science ®Google Scholar
• Kappos L, Fox RJ, Burcklen M, et al. Ponesimod compared with teriflunomide in patients with relapsing multiple sclerosis in the active-comparator phase 3 OPTIMUM study: a randomized clinical trial. JAMA Neurol. 2021;78(5):558–567.
   PubMed Web of Science ®Google Scholar
• Amato MP, Goretti B, Brescia Morra V, et al. Effects of 2-year treatment with dimethyl fumarate on cognition and functional impairment in patients with relapsing remitting multiple sclerosis. Neurol Sci. 2020;41(11):3185–3193.
   PubMed Web of Science ®Google Scholar
• Neuhaus O, Köhler W, Then Bergh F, et al. Glatiramer acetate treatment in multiple sclerosis-associated fatigue-beneficial effects on self-assessment scales but not on molecular markers. Biomolecules. 2021;11(3):393.
   PubMed Web of Science ®Google Scholar
• Razazian N, Kazeminia M, Moayedi H, et al. The impact of physical exercise on the fatigue symptoms in patients with multiple sclerosis: a systematic review and meta-analysis. BMC Neurol. 2020;20(1):93.
   PubMed Web of Science ®Google Scholar
• Judica E, Martinelli Boneschi F, Ungaro D, et al. Impact of fatigue on the efficacy of rehabilitation in multiple sclerosis. J Neurol. 2011;258(5):835–839.
   PubMed Web of Science ®Google Scholar
• Taul-Madsen L, Connolly L, and Dennett R, et al. Is aerobic or resistance training the most effective exercise modality for improving lower extremity physical function and perceived fatigue in people with multiple sclerosis? A Systematic Review and Meta-analysis. Arch Phys Med Rehabil . 2021;102(10):2032–2048.
   PubMed Web of Science ®Google Scholar
• Grazioli E, Tranchita E, Borriello G, et al. The effects of concurrent resistance and aerobic exercise training on functional status in patients with multiple sclerosis. Curr Sports Med Rep. 2019;18(12):452–457.
   PubMed Web of Science ®Google Scholar
• Sebastião E, Hubbard EA, Klaren RE, et al. Fitness and its association with fatigue in persons with multiple sclerosis. Scand J Med Sci Sports. 2017;27(12):1776–1784.
   PubMed Web of Science ®Google Scholar
• Johansson S, Skjerbæk AG, Nørgaard M, et al. Associations between fatigue impact and lifestyle factors in people with multiple sclerosis - The Danish MS hospitals rehabilitation study. Mult Scler Relat Disord. 2021;50:102799.
   PubMed Web of Science ®Google Scholar
• Kahraman T, Ozdogar AT, Abasiyanik Z, et al. Associations between smoking and walking, fatigue, depression, and health-related quality of life in persons with multiple sclerosis. Acta Neurol Belg. 2021;121(5):1199–1206.
   PubMed Web of Science ®Google Scholar
• Heine M, Verschuren O, Hoogervorst EL, et al. Does aerobic training alleviate fatigue and improve societal participation in patients with multiple sclerosis? A randomized controlled trial. Mult Scler. 2017;23(11):1517–1526.
   PubMed Web of Science ®Google Scholar
• Feys P, Moumdjian L, Van Halewyck F, et al. Effects of an individual 12-week community-located “start-to-run” program on physical capacity, walking, fatigue, cognitive function, brain volumes, and structures in persons with multiple sclerosis. Mult Scler. 2019;25(1):92–103.
   PubMed Web of Science ®Google Scholar
• Chen Y, Xu S, Shen J, et al. Effect of exercise on fatigue in multiple sclerosis patients: a network meta-analysis. Int J Sports Med. 2021;42(14):1250–1259.
   PubMed Web of Science ®Google Scholar
• Fleming KM, Coote SB, Herring MP. Home-based Pilates for symptoms of anxiety, depression and fatigue among persons with multiple sclerosis: an 8-week randomized controlled trial. Mult Scler. 2021;27(14):2267–2279.
   PubMed Web of Science ®Google Scholar
• Miller P, Soundy A. The pharmacological and non-pharmacological interventions for the management of fatigue related multiple sclerosis. J Neurol Sci. 2017;381:41–54.
   PubMed Web of Science ®Google Scholar
• Garrett M, Hogan N, Larkin A, et al. Exercise in the community for people with minimal gait impairment due to MS: an assessor-blind randomized controlled trial. Mult Scler. 2013;19(6):782–789.
   PubMed Web of Science ®Google Scholar
• Van Geel F, Van Asch P, Veldkamp R, et al. Effects of a 10-week multimodal dance and art intervention program leading to a public performance in persons with multiple sclerosis - A controlled pilot-trial. Mult Scler Relat Disord. 2020;44:102256.
   PubMed Web of Science ®Google Scholar
• Arewasikporn A, Turner AP, Alschuler KN, et al. Cognitive and affective mechanisms of pain and fatigue in multiple sclerosis. Health Psychol. 2018;37(6):544–552.
   PubMed Web of Science ®Google Scholar
• Genova HM, Lancaster K, Lengenfelder J, et al. Relationship between social cognition and fatigue, depressive symptoms, and anxiety in multiple sclerosis. J Neuropsychol. 2020;14(2):213–225.
   PubMed Web of Science ®Google Scholar
• Knowles LM, Arewasikporn A, Kratz AL, et al. Early treatment improvements in depression are associated with overall improvements in fatigue impact and pain interference in adults with multiple sclerosis. Ann Behav Med. 2021;55(9):833–843.
   PubMed Web of Science ®Google Scholar
• Beitollahi M, Forouzi MA, Tirgari B, et al. Fatigue, stigma, and mood in patients with multiple sclerosis: effectiveness of guided imagery. BMC Neurol. 2022;22(1):152.
   PubMed Web of Science ®Google Scholar
• Sauder T, Hansen S, Bauswein C, et al. Mindfulness training during brief periods of hospitalization in multiple sclerosis (MS): beneficial alterations in fatigue and the mediating role of depression. BMC Neurol. 2021;21(1):390.
   PubMed Web of Science ®Google Scholar
• Sauder T, Keune PM, Müller R, et al. Trait mindfulness is primarily associated with depression and not with fatigue in multiple sclerosis (MS): implications for mindfulness-based interventions. BMC Neurol. 2021;21(1):115.
   PubMed Web of Science ®Google Scholar
• Harrison AM, Safari R, Mercer T, et al. Which exercise and behavioural interventions show most promise for treating fatigue in multiple sclerosis? A network meta-analysis. Mult Scler. 2021;27(11):1657–1678.
   PubMed Web of Science ®Google Scholar
• Alketbi A, Basit S, Hamza N, et al. The added value of cognition-targeted exercise versus symptom-targeted exercise for multiple sclerosis fatigue: a randomized controlled pilot trial. PLoS One. 2021;16(11):e0258752.
   PubMed Web of Science ®Google Scholar
• Tecchio F, Cancelli A, Cottone C, et al. Multiple sclerosis fatigue relief by bilateral somatosensory cortex neuromodulation. J Neurol. 2014;261(8):1552–1558.
   PubMed Web of Science ®Google Scholar
• Cancelli A, Cottone C, Giordani A, et al. Personalized, bilateral whole-body somatosensory cortex stimulation to relieve fatigue in multiple sclerosis. Mult Scler. 2018;24(10):1366–1374.
   PubMed Web of Science ®Google Scholar
• Mortezanejad M, Ehsani F, Masoudian N, et al. Comparing the effects of multi-session anodal trans-cranial direct current stimulation of primary motor and dorsolateral prefrontal cortices on fatigue and quality of life in patients with multiple sclerosis: a double-blind, randomized, sham-controlled trial. Clin Rehabil. 2020;34(8):1103–1111.
   PubMed Web of Science ®Google Scholar
• Coe S, Tektonidis TG, Coverdale C, et al. A cross sectional assessment of nutrient intake and the association of the inflammatory properties of nutrients and foods with symptom severity in a large cohort from the UK multiple sclerosis registry. Nutr Res. 2021;85:31–39.
   PubMed Web of Science ®Google Scholar
• Moravejolahkami AR, Paknahad Z, Chitsaz A. Association of dietary patterns with systemic inflammation, quality of life, disease severity, relapse rate, severity of fatigue and anthropometric measurements in MS patients. Nutr Neurosci. 2020;23(12):920–930.
   PubMed Web of Science ®Google Scholar
• Mousavi-Shirazi-Fard Z, Mazloom Z, Izadi S, et al. The effects of modified anti-inflammatory diet on fatigue, quality of life, and inflammatory biomarkers in relapsing-remitting multiple sclerosis patients: a randomized clinical trial. Int J Neurosci. 2021;131(7):657–665.
   PubMed Web of Science ®Google Scholar
• Bertoglio JC, Baumgartner M, Palma R, et al. Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study. BMC Neurol. 2016;16(1):77.
   PubMedGoogle Scholar
• Rahimlou M, Hosseini SA, Majdinasab N, et al. Effects of long-term administration of Multi-Strain Probiotic on circulating levels of BDNF, NGF, IL-6 and mental health in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial. Nutr Neurosci. 2022;25(2):411–422.
   PubMed Web of Science ®Google Scholar
• Toosy A, Ciccarelli O, Thompson A. Symptomatic treatment and management of multiple sclerosis. Handb Clin Neurol. 2014;122:513–562.
   PubMedGoogle Scholar
• Perez DQ, Espiritu AI, Jamora RDG. Efficacy and safety of amantadine for the treatment of fatigue in multiple sclerosis: a systematic review and meta-analysis. Neurodegener Dis Manag. 2020;10(6):383–395.
   PubMed Web of Science ®Google Scholar
• Rocca MA, Valsasina P, Colombo B, et al., Cortico-subcortical functional connectivity modifications in fatigued multiple sclerosis patients treated with fampridine and amantadine. Eur J Neurol.2021; 28(7): 2249–2258.
   PubMed Web of Science ®Google Scholar
• Nourbakhsh B, Revirajan N, Morris B, et al. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial. Lancet Neurol. 2021;20(1):38–48.
   PubMed Web of Science ®Google Scholar
• Yang T-T, Wang L, and Deng X-Y, et al. Pharmacological treatments for fatigue in patients with multiple sclerosis: a systematic review and meta-analysis. J Neurol Sci. 2017;380:256–261.
   PubMed Web of Science ®Google Scholar
• Goodman AD, Cohen JA, Cross A, et al. Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study. Mult Scler. 2007;13(3):357–368.
   PubMed Web of Science ®Google Scholar
• Bakirtzis C, Konstantinopoulou E, Langdon DW, et al. Long-term effects of prolonged-release fampridine in cognitive function, fatigue, mood and quality of life of MS patients: the IGNITE study. J Neurol Sci. 2018;395:106–112.
   PubMed Web of Science ®Google Scholar
• Broicher SD, Filli L, Geisseler O, et al. Positive effects of fampridine on cognition, fatigue and depression in patients with multiple sclerosis over 2 years. J Neurol. 2018;265(5):1016–1025.
   PubMed Web of Science ®Google Scholar
• Mitsikostas DD, Doskas T, Gkatzonis S, et al. A prospective, observational, cohort study to assess the efficacy and safety of prolonged-release fampridine in cognition, fatigue, depression, and quality of life in multiple sclerosis patients: the FAMILY study. Adv Ther. 2021;38(3):1536–1551.
   PubMed Web of Science ®Google Scholar
• Cocco E, Fadda P. Treatment of multiple sclerosis fatigue with the synthetic psychoactive drug modafinil. Exp Neurol. 2022;347:113906.
   PubMed Web of Science ®Google Scholar
• Bourdette D. Are drugs for multiple sclerosis fatigue just placebos? Lancet Neurol. 2021;20(1):20–21.
   PubMed Web of Science ®Google Scholar
• Natsheh JY, DeLuca J, Costa SL, et al. Methylphenidate may improve mental fatigue in individuals with multiple sclerosis: a pilot clinical trial. Mult Scler Relat Disord. 2021;56:103273.
   PubMedGoogle Scholar
• Falsafi Z, Tafakhori A, Agah E, et al. Safety and efficacy of memantine for multiple sclerosis-related fatigue: a pilot randomized, double-blind placebo-controlled trial. J Neurol Sci. 2020;414:116844.
   PubMed Web of Science ®Google Scholar
• Bahji A, Vazquez GH, Zarate CA Jr. Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis. J Affect Disord. 2021;278:542–555.
   PubMed Web of Science ®Google Scholar
• Rosenblat JD, Carvalho AF, Li M, et al. Oral Ketamine for Depression: a Systematic Review. J Clin Psychiatry. 2019;80(3). 10.4088/JCP.18r12475.
   PubMed Web of Science ®Google Scholar
• Fitzgerald KC, Morris B, Soroosh A, et al. Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis-related fatigue. Mult Scler. 2021;27(6):942–953.
   PubMed Web of Science ®Google Scholar
• Nourbakhsh B, Waubant E, Evers AWM, et al. Ethical considerations in the treatment of multiple sclerosis fatigue. Mult Scler Relat Disord. 2021;54:103129.
   PubMedGoogle Scholar
• Hanken K, Sander C, Schlake HP, et al. Fatigue in Multiple Sclerosis is related to relapses, autonomic dysfunctions and introversion: a quasi-experimental study. Mult Scler Relat Disord. 2019;36:101401.
   PubMed Web of Science ®Google Scholar
• Mäurer M, Comi G, Freedman MS, et al. Multiple sclerosis relapses are associated with increased fatigue and reduced health-related quality of life - A post hoc analysis of the TEMSO and TOWER studies. Mult Scler Relat Disord. 2016;7:33–40.
   PubMed Web of Science ®Google Scholar